Amalia Capilla | CEO
Miramoon Pharma
Dr. Amalia Capilla is Chief Executive Officer of Miramoon Pharma, bringing more than 20 years of experience in regenerative medicine, gene and cell therapy, and translational research. She earned a PhD in Molecular Biology from the University of Valencia and is currently pursuing an MBA at EDEM Business School.
Her career spans leadership roles in biotechnology companies and academic institutions, including Director of Project Management at EpiDisease, Head of Operations at Tyris Therapeutics, and Director of Diabetes Cell Therapy at Sigilon Therapeutics (Cambridge, MA), where seh has led multidisciplinary teams, coordinated CRO and CMO collaborations, managed clinical operations, and overseen technology transfer processes
Dr. Capilla’s postdoctoral research at Boston University and UC San Diego yielded key publications on developmental biology and induced pluripotent stem cell–derived organoids, 3D bioprinting, and wound healing biology, resulting in 18 peer-reviewed publications in high-impact journals.
She is an active mentor in international STEM programs.
Appearances:
Day 2 - World Orphan Drug Congress USA 2026 @ 12:10
Showcase 4: MP-004: A First-in-Class Therapy Targeting Retinal Degenerative Disorders
Miramoon Pharma is developing MP-004, a first-in-class small molecule therapy for retinitis pigmentosa and other inherited retinal disorders driven by disrupted intracellular calcium homeostasis.
Designed for topical delivery, MP-004 crosses the blood-retinal barrier to efficiently reach photoreceptors. In murine models, it significantly preserves cell survival, retinal structure, and 50–70% of photoreceptor function (IOVS, 2025).
MP-004 has received FDA and EMA orphan drug designation and has completed preclinical studies with no observed toxicity or tissue accumulation. We are preparing to initiate Phase I clinical trials in Q1 2027 to demonstrate a delay in disease progression and preserve vision in patients with retinitis pigmentosa
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events